Insider · CIK 0001790029
Carmen Bozic
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Mar 3, 2026, latest Jun 30, 2026.
Carmen Bozic files SEC Form 4 as officer at VRTX (VERTEX PHARMACEUTICALS INC / MA). Since Mar 3, 2026, Carmen Bozic has reported 0 open-market buys worth $0 and 10 open-market sells worth $11M, the latest filed on Jun 30, 2026.
A track record needs three past buys with six months of prices behind them; Carmen Bozic has 0, so none is measured yet.
The newest scored trade: sold $288k of VRTX on Jun 26, 2026, filed Jun 30, 2026, scored 9 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 10 sells worth $11M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRTX: VERTEX PHARMACEUTICALS INC / MA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 9Weak | VERTEX PHARMACEUTICALS INC / MA | $288k 596 shares | -4% | +34% from low-2% from high | |
| 12Weak | VERTEX PHARMACEUTICALS INC / MA | $471k 1,020 shares | -6% | +23% from low-10% from high | |
| 25Weak | VERTEX PHARMACEUTICALS INC / MA | $1.8M 4,062 shares | -19% | +23% from low-10% from high | |
| 17Weak | VERTEX PHARMACEUTICALS INC / MA | $785k 1,745 shares | -8% | +22% from low-10% from high | |
| 26Weak | VERTEX PHARMACEUTICALS INC / MA | $888k 1,974 shares | -8% | +22% from low-10% from high | |
| 30Weak | VERTEX PHARMACEUTICALS INC / MA | $614k 1,354 shares | -5% | +19% from low-12% from high | |
| 40Moderate | VERTEX PHARMACEUTICALS INC / MA | $3.1M 6,988 shares | -21% | +22% from low-10% from high | |
| 20Weak | VERTEX PHARMACEUTICALS INC / MA | $1.1M 2,329 shares | -7% | +18% from low-15% from high | |
| 35Weak | VERTEX PHARMACEUTICALS INC / MA | $1.1M 2,329 shares | -6% | +28% from low-9% from high | |
| 35Weak | VERTEX PHARMACEUTICALS INC / MA | $1.1M 2,329 shares | -6% | +36% from low-3% from high |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -596 | $482.50 | $288k | 15,337 | Jun 30, 2026 |
| Jun 18, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,020 | $462.17 | $471k | 15,933 | Jun 23, 2026 |
| Jun 15, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -4,062 | $450.00 | $1.8M | 16,953 | Jun 17, 2026 |
| Jun 5, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,745 | $450.00 | $785k | 21,015 | Jun 9, 2026 |
| May 29, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,974 | $450.00 | $888k | 22,760 | Jun 2, 2026 |
| May 15, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,354 | $453.45 | $614k | 24,734 | May 19, 2026 |
| May 12, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -6,988 | $450.00 | $3.1M | 26,088 | May 14, 2026 |
| Mar 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,329 | $450.95 | $1.1M | 33,076 | Mar 31, 2026 |
| Mar 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,329 | $481.79 | $1.1M | 35,405 | Mar 17, 2026 |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,329 | $480.31 | $1.1M | 37,734 | Mar 3, 2026 |
| Feb 24, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -1,453 | $485.11 | $705k | 40,063 | Feb 26, 2026 |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +5,375 | $0.00 | $0 | 43,428 | Feb 19, 2026 |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -1,912 | $483.75 | $925k | 41,516 | Feb 19, 2026 |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -3,804 | $487.76 | $1.9M | 38,053 | Feb 18, 2026 |
| Feb 10, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -2,145 | $468.41 | $1.0M | 41,857 | Feb 12, 2026 |
| Jan 22, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +7,866 | $0.00 | $0 | 40,535 | Jan 26, 2026 |
| Jan 22, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +3,467 | $0.00 | $0 | 44,002 | Jan 26, 2026 |
| Feb 26, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -4,962 | $479.61 | $2.4M | 32,669 | Feb 28, 2025 |
| Feb 24, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -3,310 | $483.28 | $1.6M | 37,631 | Feb 26, 2025 |
| Feb 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -1,912 | $463.46 | $886k | 40,941 | Feb 19, 2025 |
| Feb 12, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +5,546 | $0.00 | $0 | 42,853 | Feb 14, 2025 |
| Feb 10, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -2,142 | $467.98 | $1.0M | 37,307 | Feb 12, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +10,262 | $0.00 | $0 | 33,521 | Feb 6, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +5,928 | $0.00 | $0 | 39,449 | Feb 6, 2025 |
Questions about Carmen Bozic
Answered from the filings on this page, as of the latest one.
Is Carmen Bozic buying or selling?
In the last 12 months Carmen Bozic reported 0 open-market buys worth $0 and 10 open-market sells worth $11M on SEC Form 4; the latest was sold $288k of VRTX on Jun 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Carmen Bozic's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carmen Bozic has 0.
Where does Carmen Bozic file Form 4?
Carmen Bozic has filed Form 4 at VRTX (VERTEX PHARMACEUTICALS INC / MA) as EVP and CMO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.